July 23, 2007 - Varian Medical Systems is showcasing its I-Response technology from Cedara, a software designed for assessing how tumors respond to therapy at the biological level, often before changes in tumor shape or size become visible, at the 49th Annual Meeting of the American Association of Physicists in Medicine (AAPM), taking place July 22-26, 2007.
The I-Response tool tracks changes in tumor tissue at the cellular and metabolic levels over time using sophisticated PET/CT analysis and a unique MR technique called functional diffusion mapping (fDM). This provides the potential for clinicians to monitor the impact of anti-cancer drugs and radiation therapy early in the course of treatment, so they can adapt their treatment strategies and personalize treatment plans.
For more information: www.varian.com
June 29, 2026 
